New data from the 2017 Australian Genetics of Depression Study has confirmed that thousands of adults are using multiple medications to manage their illness.
The preliminary release of data from the results showed that genetic profiling could help provide more respective treatments for people suffering from depression. The data surveyed from more than 10,000 Australian adults, also shows around 30% of participants stating that their medication works, but there was also a large volume of those surveyed who have had ongoing concerns with regards to side effects, resulting in prescriptions being switched on more than one occasion in order to find a suitable anti-depressant. This data confirms what both patients and medical professionals have been suspected for a long time.
Professor Ian Hickie from the Brain and Mind Centre at the University of Sydney says the medical industry had reached its limit of knowledge in treating depression. “Given our lack of diagnostic methods to predict different responses to anti-depressants, to forecast the potential for intolerable side-effects, we are exposing those battling clinical depression to trial and error, which is often slow to deliver significant benefits”, he said.
Clinical depression is a common mental illness, often referred to as depression, which will affect almost one in five people during their lifetime. The World Health Organization (WHO) predicts that by 2020, clinical depression will impose the second highest burden of any disease in Australia and other advanced countries.
The overarching objective of the Australian Genetics of Depression Study is to learn more about the genetic drivers of clinical depression, and the genetic factors that influence the effectiveness of various clinical depression treatments.
Study researchers are working to recruit more than 20,000 Australians aged 18+ to the study who:
To register for this survey visit: www.geneticsofdepression.org.au
Source: SBS News
Comments will be approved before showing up.